Less Ads, More Data, More Tools Register for FREE

Pin to quick picksUbsetfusmca Regulatory News (UMC)

Share Price Information for Ubsetfusmca (UMC)

Share Price is delayed by 15 minutes
Get Live Data
662.90    0.00 (0.00%)
Bid:
662.40
Ask:
663.40
Spread: 1.00 (0.151%)
Market Cap: -
UMC Live PriceLast checked at - London Stock Exchange

Intraday Ubsetfusmca Share Chart

Directorate Change

30 Apr 2010 13:42

RNS Number : 1588L
UMECO PLC
30 April 2010
 



 30 April 2010

Umeco plc ("Umeco")

Adrian Auer appointed as Senior Independent Director of Umeco plc

Umeco, the advanced composite materials and supply chain services company, announces that it has appointed Adrian Auer as Non-Executive Director and Senior Independent Director with effect from 30 April 2010. Adrian Auer has also become a member of the audit committee from that date.

Adrian Auer holds a number of senior Board positions. He is Chairman of Shanks Group plc and Readymix plc, Non-Executive Director of Electrocomponents plc and Chairman of the charity Addaction.

He has held the position of Finance Director in a number of major companies, notably in the building materials and construction sectors, in addition to senior finance positions with BP and ICI.

Neil Johnson, Chairman of Umeco, said:

"We are delighted that Adrian has agreed to join the Board as Senior Independent Director. His breadth of international corporate experience, both in Executive and Non-Executive roles, will be invaluable to the Board."

Until June 2009 Adrian Auer was a Non-Executive Director at Filtrona plc. He was a Non-Executive Director of Foseco Limited (formerly Foseco plc) until April 2008, Hiscox plc until December 2006 and Bespak plc until April 2006. There are no further details that are required to be disclosed in respect of his appointment under LR 9.6.13R of the Listing Rules of the UK Listing Authority.

- Ends -

For further information, please contact:-

 

Tulchan Communications

Tel: +44 (0) 207 353 4200

John Sunnucks

Lucy Legh

 

 

Further Information on Umeco plc

Umeco is a leading innovator in distribution and supply chain management to the aerospace & defenceindustries, harnessing new methods for enhancing its customers' performance and profitability. Umeco also has significant manufacturing interests in advanced composite materials for a growing range of applications in its core aerospace anddefencemarkets and in other high performance technology industries such as motor sport, automotive and wind energy.

 

Listed on the London Stock Exchange, Umeco had revenue from continuing operations of £415.3 million in the year to 31 March 2009.

 

Umeco is managed through two business streams:-

Umeco Composites - comprises a Structural Materials business and a Process Materials business. With seven operating units located throughout the UK, Europe and the US, it provides a range of services, products, design expertise and tooling solutions principally to the aerospace market and other users of advanced composite materials.

 

Customers include Boeing, Airbus, BAE Systems, manufacturers of wind turbine blades, a number of manufacturers of high performance super cars and Formula 1 teams.

 

Umeco Supply Chain - a leading international provider of value-added distribution and supply chain outsourcing services to customers in the aerospace & defence market. With its specialisation in the supply of small and medium value components and sophisticated IT systems, its growing global customer base can enjoy significant operational, cost and working capital benefits.

 

Customers include Rolls-Royce plc, BAE Systems, Safran Group, Parker Aerospace, Goodrich, Thales Aerospace, Turbomeca, ATK, Lockheed Martin and the US Department of Defense.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOADMGFDZGMGGZM
Date   Source Headline
25th Mar 202611:40 amRNSNet Asset Value(s)
24th Mar 202610:58 amRNSNet Asset Value(s)
23rd Mar 202611:44 amRNSNet Asset Value(s)
20th Mar 202611:08 amRNSNet Asset Value(s)
19th Mar 202612:54 pmRNSNet Asset Value(s)
18th Mar 202610:26 amRNSNet Asset Value(s)
16th Mar 202610:18 amRNSNet Asset Value(s)
13th Mar 202610:27 amRNSNet Asset Value(s)
12th Mar 202610:22 amRNSNet Asset Value(s)
11th Mar 202610:24 amRNSNet Asset Value(s)
9th Mar 202610:27 amRNSNet Asset Value(s)
6th Mar 202610:47 amRNSNet Asset Value(s)
5th Mar 202610:27 amRNSNet Asset Value(s)
4th Mar 20262:50 pmRNSNet Asset Value(s)
3rd Mar 202611:19 amRNSNet Asset Value(s)
2nd Mar 202610:56 amRNSNet Asset Value(s)
27th Feb 202610:37 amRNSNet Asset Value(s)
26th Feb 202610:21 amRNSNet Asset Value(s)
25th Feb 202610:26 amRNSNet Asset Value(s)
24th Feb 202610:25 amRNSNet Asset Value(s)
23rd Feb 202610:21 amRNSNet Asset Value(s)
20th Feb 202610:32 amRNSNet Asset Value(s)
19th Feb 202610:37 amRNSNet Asset Value(s)
18th Feb 202610:28 amRNSNet Asset Value(s)
16th Feb 202610:31 amRNSNet Asset Value(s)
13th Feb 202610:30 amRNSNet Asset Value(s)
12th Feb 202610:33 amRNSNet Asset Value(s)
11th Feb 202610:32 amRNSNet Asset Value(s)
10th Feb 202611:01 amRNSNet Asset Value(s)
9th Feb 202611:06 amRNSNet Asset Value(s)
6th Feb 202611:26 amRNSNet Asset Value(s)
5th Feb 202610:39 amRNSNet Asset Value(s)
4th Feb 202610:23 amRNSNet Asset Value(s)
3rd Feb 202610:31 amRNSNet Asset Value(s)
2nd Feb 202610:27 amRNSNet Asset Value(s)
2nd Feb 20267:00 amRNSNet Asset Value(s)
29th Jan 202610:39 amRNSNet Asset Value(s)
28th Jan 202610:11 amRNSNet Asset Value(s)
27th Jan 202610:43 amRNSNet Asset Value(s)
26th Jan 202610:11 amRNSNet Asset Value(s)
22nd Jan 202610:18 amRNSNet Asset Value(s)
21st Jan 202610:37 amRNSNet Asset Value(s)
19th Jan 202610:43 amRNSNet Asset Value(s)
16th Jan 202611:20 amRNSNet Asset Value(s)
15th Jan 202610:26 amRNSNet Asset Value(s)
14th Jan 202610:27 amRNSNet Asset Value(s)
13th Jan 202610:30 amRNSNet Asset Value(s)
12th Jan 202610:23 amRNSNet Asset Value(s)
9th Jan 202610:34 amRNSNet Asset Value(s)
8th Jan 202610:29 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.